DaVita (DVA) Competitors

DaVita (NYSE:DVA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, community ranking, valuation and profitability.

Does the media favor DVA or FMS?

In the previous week, DaVita had 8 more articles in the media than Fresenius Medical Care. MarketBeat recorded 14 mentions for DaVita and 6 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.15 beat DaVita's score of 0.75 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	6 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer DVA or FMS?

DaVita received 87 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.70% of users gave DaVita an outperform vote while only 53.99% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
DaVita	Outperform Votes 493 61.70%	Underperform Votes 306 38.30%
Fresenius Medical Care	Outperform Votes 406 53.99%	Underperform Votes 346 46.01%

Which has stronger valuation & earnings, DVA or FMS?

DaVita has higher earnings, but lower revenue than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$12.14B	1.01	$691.53M	$8.80	15.89
Fresenius Medical Care	$21.05B	0.61	$540.07M	$0.89	24.69

Which has more volatility & risk, DVA or FMS?

DaVita has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in DVA or FMS?

90.1% of DaVita shares are owned by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are owned by institutional investors. 1.4% of DaVita shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Is DVA or FMS more profitable?

DaVita has a net margin of 6.61% compared to Fresenius Medical Care's net margin of 2.48%. DaVita's return on equity of 68.52% beat Fresenius Medical Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.61%	68.52%	4.98%
Fresenius Medical Care	2.48%	5.29%	2.30%

Do analysts prefer DVA or FMS?

DaVita currently has a consensus price target of $144.67, indicating a potential upside of 3.47%. Fresenius Medical Care has a consensus price target of $24.00, indicating a potential upside of 9.24%. Given Fresenius Medical Care's higher possible upside, analysts plainly believe Fresenius Medical Care is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Fresenius Medical Care	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

Summary

DaVita beats Fresenius Medical Care on 13 of the 18 factors compared between the two stocks.